JPRN-UMIN000016056
Recruiting
Phase 2
PhaseII study of pleurectomy/decortication and intraoperative intrapleural hyperthermic cisplatin perfusion - PhaseII study of pleurectomy/decortication and intraoperative intrapleural hyperthermic cisplatin perfusion
Department of Thoracic Surgery, Tokyo Medical and Dental University0 sites35 target enrollmentDecember 26, 2014
Overview
- Phase
- Phase 2
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- Department of Thoracic Surgery, Tokyo Medical and Dental University
- Enrollment
- 35
- Status
- Recruiting
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •past history of malignant mesothelioma severe complication of heart, liver or renal function interstitial pneumonia possibility of pregnancy,patient with pregnancy past history of severe drug allergy concomitant cancer of other organs
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
EORTC randomized phase II study of pleurectomy/decortication preceded or followed by chemotherapy in patients with early stage malignant pleural mesothelioma.'Mesothelioma' and 'pleural tumor'100274121003559710038737NL-OMON53100European Organisation for Research in Treatment of Cancer (EORTC)18
Recruiting
Phase 2
Phase II clinical trial of pleurodesis with a 50% glucose solution for persistent air leak after pulmonary resectioPostoperative persistent air leak or postoperative pneumothorax after pulmonary resectionJPRN-UMIN000024987Hokkaido Cancer Center26
Completed
Not Applicable
Palliative pleurectomy / decortication in patients with malignant pleural mesothelioma after standard chemotherapy. A multicenter, randomised, phase III study.mesothelioom100274121003559710006295NL-OMON33742Erasmus MC, Universitair Medisch Centrum Rotterdam160
Active, not recruiting
Not Applicable
Thoracic Mesothelioma: Surgery with or without subsequent lavage at high temperature with addition of chemotherapymalignant pleuramesotheliomaMedDRA version: 16.1Level: PTClassification code 10027407Term: Mesothelioma malignantSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)Therapeutic area: Diseases [C] - Cancer [C04]EUCTR2013-003830-34-DEAsklepios Fachkliniken München Gauting
Recruiting
Phase 3
Pleurodesis treatment with 50% glucoseIRCT20201013049017N1Esfahan University of Medical Sciences64